18th January 2022
Trials underway in Moorfields and Guy’s & St Thomas’
DemDx, the AI clinical reasoning platform that supports front-line healthcare practitioners’ clinical assessment at the first point of patient contact, is one of the digital health companies selected for DigitalHealth.London’s Accelerator programme.
DemDx is trialling its innovative AI platform at Moorfields Eye Hospital NHS Trust and Guy’s and St Thomas’ NHS Foundation Trust.
The 21 small and medium-sized enterprises (SMEs) selected for the Accelerator 2022 programme have digital solutions or services that have the highest potential to meet London’s NHS and social care challenges.
Lorin Gresser, DemDx Chief Executive commented:
“We are delighted to be selected for this programme – it’s another important endorsement of the business, particularly at a time when we are trialling our AI clinical reasoning platform at two leading London hospitals.
One of the largest challenges for primary and acute care delivery is the lack of workforce resourcing and training to adequately meet growing patient demand. We are helping to redefine workforce and healthcare professional roles at a time of particularly operational stress.
The only way forward is to develop a new model of front-line care with an expanded multi-disciplinary team drawing on the skills of other healthcare professionals. These multi-disciplined teams will greatly benefit from the use of AI-based fully transparent clinical reasoning platforms in order to enhance clinical assessment at the first point of patient contact as well as make considerable efficiencies across the whole patient care journey.”
Now in its sixth consecutive year, the NHS-delivered programme, match funded by the European Regional Development Fund, has supported some of the most effective digital innovations now being used by the NHS.
Jenny Thomas, Programme Director, DigitalHealth.London, said:
“We are delighted to announce today the 21 digital health companies joining our sixth
DigitalHealth.London Accelerator cohort. The application process for this year’s programme
was competitive as ever and as such, the final 21 companies truly are the ones to watch in
the digital health space. We look forward to working with them and continuing to play our
part in supporting the NHS and social care through digital transformation.”
Sonia Patel, Chief Information Officer, NHSX, said:
“The DigitalHealth.London Accelerator programme has established itself as an important
player in supporting the NHS and social care to make the most of the opportunities digital
health offers. I look forward to seeing the next group of innovators bringing their solutions
to London’s NHS.”
DigitalHealth.London’s Accelerator aims to speed up the adoption of technology in London’s
NHS, relieving high pressure on services and empowering patients to manage their health. for
every £1 spent on the programme through the AHSNs, £12.70 is saved for the NHS*. It works
with around 20 high potential SMEs over a 12-month period, giving bespoke support and
advice, a programme of expert-led workshops and events, and brokering meaningful
connections between innovators and NHS organisations with specific challenges. The
companies successful in getting onto the Accelerator programme have been chosen through
a rigorous and highly competitive selection process, involving expert NHS and industry panel
assessments, interviews, and due diligence checks.
This year the companies on the programme will benefit from international partnerships with
two US Accelerators, Cedars-Sinai and Mass Challenge**. The two partnerships will provide
opportunities for the companies to network with global peers, showcase their
products/services to key international stakeholders and gain the tools to navigate a new
For more information about the companies on the programme visit:
Lorin Gresser, Chief Executive email@example.com
Tel: 07990 858548
Notes to editors
DemDx is a MedTech business with an artificial intelligence (AI) powered clinical reasoning
platform to enable frontline healthcare professionals to make initial clinical assessments
more effectively and efficiently. The platform is the only one able to support direct frontline
practitioners in their clinical assessments.
Using DemDX’s technology on any mobile or desk top device, frontline practitioners are
able to augment their initial clinical assessment more accurately and consistently thereby
improving overall clinical care and reducing healthcare operating costs, particularly with
regard to doctors’ time.
The full transparent medically-certified platform is the only such licensed tool available to
frontline practitioners. It is built on a database developed by over 100 doctors covering 15
specialties, over 2,800 diagnoses with more than 1.5m clinical pathways.
DemDx was founded by Dr Lorin Gresser and Steve Varley (CTO). Dr Mariane Melo is the
Chief Medical Officer. Lorin was a winner of Women in Innovation award and Mariane was
nominated in 2021 for the Forbes 30 under 30 Europe Science and Healthcare list.
Dem Dx has raised over 3m to date, having just completed a funding round. The businesswas also awarded 1.1m from the NHSx to develop further its AI technology.
The DigitalHealth.London Accelerator was the first programme of DigitalHealth.London. It is
aimed at digital health companies that would benefit from better engagement with the NHS
and the wider health sector, in order to refine and develop products and services that meet
the needs of the system.
The DigitalHealth.London Accelerator is run by a consortium of founding partners comprising
of two of London’s Academic Health Science Networks (AHSNs) – the Health Innovation
Network, and UCLPartners – as well as CW+ and MedCity. The programme is part-funded by
the European Regional Development Fund (ERDF) as part of the European Structural and
Investment Funds Growth Programme.
*DigitalHealth.London Accelerator Interim Evaluation report available to download here:
** Cedars-Sinai partnership announcement:
Mass Challenge partnership announcement: https://digitalhealth.london/digitalhealthlondon-
European Regional Development Fund
The project is receiving up to 3.8 million of funding from the England European Regional
Development Fund as part of the European Structural and Investment Funds Growth
Programme 2014-2020. The Ministry of Housing, Communities and Local Government (and in
London the intermediate body Greater London Authority) is the Managing Authority for
European Regional Development Fund. Established by the European Union, the European
Regional Development Fund helps local areas stimulate their economic development by
investing in projects which will support innovation, businesses, create jobs and local
For more information visit gov.uk/european-growth-funding